Malaria is one of the most devastating human infectious diseases caused by Plasmodium
spp. parasites. A search for an effective and safe vaccine is the main challenge for its …

Initiatives to eradicate malaria have a good impact on P. falciparum malaria worldwide. P.
vivax, however, still presents significant difficulties. This is due to its unique biological traits …

Ethiopia has the greatest burden of Plasmodium vivax in Africa, but little is known about the
epidemiological landscape of parasites across the country. We analysed the genomic …

Abstract “The Primate Malarias” book has been a uniquely important resource for multiple
generations of scientists, since its debut in 1971, and remains pertinent to the present day …

Background Malaria remains a severe parasitic disease, posing a significant threat to public
health and hindering economic development in sub-Saharan Africa. Ethiopia, a malaria …

Background The interaction between the Plasmodium vivax Duffy-binding protein and the
corresponding Duffy Antigen Receptor for Chemokines (DARC) is primarily responsible for …

The documentation of Plasmodium vivax malaria across Africa especially in regions where
Duffy negatives are dominant suggests possibly alternative erythrocyte invasion …

Plasmodium vivax is the most widespread cause of malaria, especially in subtropical and
temperate regions such as Asia-Pacific and America. P. vivax lactate dehydrogenase …

Plasmodium vivax blood-stage invasion into reticulocyte is critical for parasite development.
Thus, validation of novel parasite invasion ligands is essential for malaria vaccine …

Recent evidence challenges the belief that individuals who are Duffy-negative are resistant
to Plasmodium vivax due to lacking the Duffy antigen receptor for chemokines. Erythrocyte …